SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients

SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients

IntroductionFibrodysplasia ossificans progressiva (FOP) is characterized by progressive heterotopic ossification triggered by various conditions, such as trauma, infection, including COVID-19 infection, and vaccination. Although SARS-CoV-2 vaccinations prevent poor outcomes in the general population...

Full description

Bibliographic Details
Main Authors: Jitka Smetanova, Tomas Milota, Michal Rataj, Jana Hurnakova, Hana Zelena, Rudolf Horvath
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
fibrodysplasia ossificans progressive
COVID-19
SARS-CoV-2
vaccination
immunogenicity
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017232/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017232/full

Similar Items